AI can be applied to patient data in real time, allowing medical reviewer teams to actively monitor patient safety, with the AI alerting medical review teams to identify potential adverse events (AEs), data anomalies, critical issues for patients on treatment, and more.
Related Posts
The Leap from Deterministic to AI-Powered Stochastic Methods
Credit: ra2 studio | stock.adobe.com Clinical data is the cornerstone of progress in high-stakes pharmaceutical research and development. This vital…
DREAMM-7 Trial Shows Blenrep Combo Significantly Boosts Overall Survival in Relapsed/Refractory Multiple Myeloma
Credit: luchschenF | stock.adobe.com Interim findings from the Phase III DREAMM-7 trial (NCT04246047) demonstrate that the combination of Blenrep (belantamab…
FDA Grants Breakthrough Therapy Designation, Priority Review to AstraZeneca’s Imfinzi for the Treatment of Limited-Stage Small Cell Lung Cancer
Image Credit: Adobe Stock Images/pakbung The FDA has granted Breakthrough Therapy Designation and Priority Review to AstraZeneca’s Infimzi (durvalumab), indicated…